Empiric amphotericin B therapy in patients with acute leukemia.

W. M. Holleran, J. R. Wilbur, M. W. DeGregorio

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Invasive fungal infections remain a considerable problem in the management of patients with acute leukemia. This review discusses and provides guidelines for empiric treatment in such circumstances, with emphasis on the use of amphotericin B. The topics covered include the risk factors associated with the development of fungal infections; the difficulties of diagnosing a fungal infection; the empiric use of amphotericin B (with a review of clinical trials and dosing guidelines); and the role of other therapeutic measures in oral prophylaxis and treatment. Although other organisms have been shown to cause fungal infections in patients with acute leukemia, only Candida and Aspergillus species are discussed formally in terms of diagnosis and therapy.

Original languageEnglish (US)
Pages (from-to)619-624
Number of pages6
JournalReviews of Infectious Diseases
Volume7
Issue number5
StatePublished - Sep 1985

Fingerprint

Amphotericin B
Mycoses
Leukemia
Guidelines
Aspergillus
Therapeutics
Candida
Clinical Trials

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Holleran, W. M., Wilbur, J. R., & DeGregorio, M. W. (1985). Empiric amphotericin B therapy in patients with acute leukemia. Reviews of Infectious Diseases, 7(5), 619-624.

Empiric amphotericin B therapy in patients with acute leukemia. / Holleran, W. M.; Wilbur, J. R.; DeGregorio, M. W.

In: Reviews of Infectious Diseases, Vol. 7, No. 5, 09.1985, p. 619-624.

Research output: Contribution to journalArticle

Holleran, WM, Wilbur, JR & DeGregorio, MW 1985, 'Empiric amphotericin B therapy in patients with acute leukemia.', Reviews of Infectious Diseases, vol. 7, no. 5, pp. 619-624.
Holleran WM, Wilbur JR, DeGregorio MW. Empiric amphotericin B therapy in patients with acute leukemia. Reviews of Infectious Diseases. 1985 Sep;7(5):619-624.
Holleran, W. M. ; Wilbur, J. R. ; DeGregorio, M. W. / Empiric amphotericin B therapy in patients with acute leukemia. In: Reviews of Infectious Diseases. 1985 ; Vol. 7, No. 5. pp. 619-624.
@article{0786c5c4439d46f8a9598d751ebc9ae5,
title = "Empiric amphotericin B therapy in patients with acute leukemia.",
abstract = "Invasive fungal infections remain a considerable problem in the management of patients with acute leukemia. This review discusses and provides guidelines for empiric treatment in such circumstances, with emphasis on the use of amphotericin B. The topics covered include the risk factors associated with the development of fungal infections; the difficulties of diagnosing a fungal infection; the empiric use of amphotericin B (with a review of clinical trials and dosing guidelines); and the role of other therapeutic measures in oral prophylaxis and treatment. Although other organisms have been shown to cause fungal infections in patients with acute leukemia, only Candida and Aspergillus species are discussed formally in terms of diagnosis and therapy.",
author = "Holleran, {W. M.} and Wilbur, {J. R.} and DeGregorio, {M. W.}",
year = "1985",
month = "9",
language = "English (US)",
volume = "7",
pages = "619--624",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Empiric amphotericin B therapy in patients with acute leukemia.

AU - Holleran, W. M.

AU - Wilbur, J. R.

AU - DeGregorio, M. W.

PY - 1985/9

Y1 - 1985/9

N2 - Invasive fungal infections remain a considerable problem in the management of patients with acute leukemia. This review discusses and provides guidelines for empiric treatment in such circumstances, with emphasis on the use of amphotericin B. The topics covered include the risk factors associated with the development of fungal infections; the difficulties of diagnosing a fungal infection; the empiric use of amphotericin B (with a review of clinical trials and dosing guidelines); and the role of other therapeutic measures in oral prophylaxis and treatment. Although other organisms have been shown to cause fungal infections in patients with acute leukemia, only Candida and Aspergillus species are discussed formally in terms of diagnosis and therapy.

AB - Invasive fungal infections remain a considerable problem in the management of patients with acute leukemia. This review discusses and provides guidelines for empiric treatment in such circumstances, with emphasis on the use of amphotericin B. The topics covered include the risk factors associated with the development of fungal infections; the difficulties of diagnosing a fungal infection; the empiric use of amphotericin B (with a review of clinical trials and dosing guidelines); and the role of other therapeutic measures in oral prophylaxis and treatment. Although other organisms have been shown to cause fungal infections in patients with acute leukemia, only Candida and Aspergillus species are discussed formally in terms of diagnosis and therapy.

UR - http://www.scopus.com/inward/record.url?scp=0022120092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022120092&partnerID=8YFLogxK

M3 - Article

C2 - 3903941

AN - SCOPUS:0022120092

VL - 7

SP - 619

EP - 624

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 5

ER -